Correction to: CCR9 initiates epithelial–mesenchymal transition by activating Wnt/β-catenin pathways to promote osteosarcoma metastasis.
- Resource Type
- Correction Notice
- Authors
- Kong, Haoran; Yu, Wenhui; Chen, Zhuning; Li, Haonan; Ye, Guiwen; Hong, Jiacong; Xie, Zhongyu; Chen, Keng; Wu, Yanfeng; Shen, Huiyong
- Source
- Cancer Cell International. 4/13/2022, Vol. 22 Issue 1, p1-4. 4p.
- Subject
- *CHEMOKINE receptors
*EPITHELIAL-mesenchymal transition
*CELL adhesion molecules
*OSTEOSARCOMA
*CADHERINS
*METASTASIS
- Language
- ISSN
- 1475-2867
6 a The protein expression levels of active -catenin and total -catenin were downregulated in si-CCR9 group. b The protein expression levels and quantitative data of active -catenin and total -catenin in MG63 and HOS cells were shown. Overexpression of CCR9 activated the Wnt/ -catenin pathway, and the Wnt signaling inhibitor XAV-939 counteracted the activation. c Cell migration assay of MG63 and HOS cells. Correction to: CCR9 initiates epithelial-mesenchymal transition by activating Wnt/ -catenin pathways to promote osteosarcoma metastasis. [Extracted from the article]